1 | Effects of Cancer Stem Cells in Triple-Negative Breast Cancer and Brain Metastasis: Challenges and Solutions. 2020;12:2122 doi: 10.3390/cancers12082122 |
2 | Assessing chemotherapy dosing strategies in a spatial cell culture model. 2022;12: doi: 10.3389/fonc.2022.980770 |
3 | Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities. 2019;11:1569 doi: 10.3390/cancers11101569 |
4 | Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors. 2021;11: doi: 10.3389/fonc.2021.700629 |
5 | Oligometastatic Breast Cancer: Is This a Curable Entity? A Contemporary Review of the Literature. 2020;22: doi: 10.1007/s11912-020-0867-2 |
6 | Innovative Approaches in the Battle Against Cancer Recurrence: Novel Strategies to Combat Dormant Disseminated Tumor Cells. 2021;11: doi: 10.3389/fonc.2021.659963 |
7 | Dichotomous role of autophagy in cancer. 2022;16:111 doi: 10.2478/abm-2022-0014 |
8 | Inhibition of lovastatin- and docosahexaenoic acid-initiated autophagy in triple negative breast cancer reverted resistance and enhanced cytotoxicity. 2020;259:118212 doi: 10.1016/j.lfs.2020.118212 |
9 | The Roles of Autophagy and Senescence in the Tumor Cell Response to Radiation. 2020;194:103 doi: 10.1667/RADE-20-00009 |
10 | Effects of PI3K inhibition in AI-resistant breast cancer cell lines: autophagy, apoptosis, and cell cycle progression. 2021;190:227 doi: 10.1007/s10549-021-06376-4 |